Aurinia Pharmaceuticals Inc.
Ticker: 1600620
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 83.22+7.1% | 77.71+5.8% | 73.47+4.9% | 70.01+12.1% | 62.47-7.8% | 67.77+18.5% | 57.19+13.7% | 50.30 |
| Total Income | 83.22+7.1% | 77.71+5.8% | 73.47+4.9% | 70.01+12.1% | 62.47-7.8% | 67.77+18.5% | 57.19+13.7% | 50.30 |
| EXPENSES | ||||||||
| Expenditure | 36.88+1.7% | 36.28-17.0% | 43.72-12.4% | 49.93+22.9% | 40.62-27.5% | 56.02-4.6% | 58.71-7.6% | 63.56 |
| Tax | 11.37+18.8% | 9.57+2234.1% | 0.41-35.9% | 0.64-36.6% | 1.01+119.6% | 0.46-39.5% | 0.76+2.7% | 0.74 |
| PROFIT | ||||||||
| PBT | 48.79+11.1% | 43.93+37.5% | 31.96+44.2% | 22.16-9.0% | 24.35+64.4% | 14.81+900.7% | 1.48+114.8% | -10.01 |
| Net Profit | 37.41+8.9% | 34.36+8.9% | 31.55+46.7% | 21.51-7.8% | 23.34+62.6% | 14.35+1893.1% | 0.72+106.7% | -10.75 |
| KEY METRICS | ||||||||
| OPM % | 55.69%+2.38pp | 53.31%+12.82pp | 40.49%+11.80pp | 28.69%-6.29pp | 34.98%+17.64pp | 17.34%+19.98pp | -2.65%+23.70pp | -26.35% |
| NPM % | 44.96%+0.75pp | 44.21%+1.27pp | 42.95%+12.22pp | 30.73%-6.64pp | 37.37%+16.20pp | 21.17%+19.91pp | 1.26%+22.63pp | -21.37% |
| EPS | 0.29+11.5% | 0.26+8.3% | 0.24+50.0% | 0.16-5.9% | 0.17+70.0% | 0.10+900.0% | 0.01+114.3% | -0.07 |
Corporate Events
Board MeetingAUPH
20263Jun
Board Meeting
Annual General Meeting of shareholders to elect directors, a…
SEC Filing ↗